Skip to main content

Advertisement

Table 1 Characteristics of patients

From: Disruption of rhythms of molecular clocks in primary synovial fibroblasts of patients with osteoarthritis and rheumatoid arthritis, role of IL-1β/TNF

  Osteoarthritis Rheumatoid arthritis
number 17 17
age (yr) 68.8 ± 1.6 62.1 ± 3.0
sex (f/m) 14/3 13/4
C-reactive protein (mg/l) 9.4 ± 4.1 40.1 ± 14.6*
erythrocyte sedimentation rate (mm) 12.4 ± 2.6 41.5 ± 9.2*
medication   
   prednisolone (%) N.A. 88.0
   daily prednisolone (mg/d) N.A. 4.3 ± 0.5
   methotrexate (%) N.A. 35.3
   anti-TNF therapy (%) N.A. 5.9
   leflunomide (%) N.A. 29.4
   cyclosporin A (%) N.A. 5.9
   peripherally acting opioidergic drugs (%) 41.2 35.3
   Non-steroidal antiinflammatory drugs (%) 70.6 64.7
  1. *P < 0.05 for the comparison vs. osteoarthritis. Abbreviations: N.A., not applicable.
  2. Data are given as means ± SEM, percentages in parentheses, and ranges in brackets